medsovetМедицинский СоветMeditsinskiy sovet = Medical Council2079-701X2658-5790REMEDIUM GROUP Ltd.10.21518/2079-701X-2015-XX-14-19medsovet-466Research ArticleГИНЕКОЛОГИЧЕСКАЯ ЭНДОКРИНОЛОГИЯGYNECOLOGICAL ENDOCRINOLOGYЭффективность и безопасность альтернативных методов лечения менопаузальных симптомов в свете последних доказательных данныхThe efficacy and safety of alternative treatments for menopausal symptoms in light of recent evidenceЮреневаС. В.YurenevaS. V.noemail@neicon.ruИльинаЛ. М.IlyinaL. M.noemail@neicon.ruНаучный центр акушерства, гинекологии и перинатологии им. В.И. Кулакова Минздрава России, МоскваРоссияScientific center for obstetrics, gynecology and perinatology named after V.I. Kulakov, Russia’s Ministry of Health, MoscowRussian FederationАссоциация гинекологов-эндокринологовРоссияAssociation of Gynecologists Endocrinologists, MoscowRussian Federation2015301220150XX1419Copyright © Юренева С.В., Ильина Л.М., 20152015Юренева С.В., Ильина Л.М.Yureneva S.V., Ilyina L.M.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-sovet.pro/jour/article/view/466

Менопаузальная гормональная терапия (МГТ) признана наиболее эффективным методом лечения вазомоторных симптомов у женщин в переходный период и в постменопаузе [1, 2]. Хотя с этой целью широко используются также различные альтернативные методы лечения, имеется недостаточно убедительных доказательств в их поддержку. За последние годы мы наблюдаем расцвет отрасли т. н. натуральных растительных препаратов, хотя эффективность большинства из них не превышает воздействие плацебо [3]. Многие врачи и женщины ошибочно полагают, что отсутствие данных о каком-либо неблагоприятном влиянии альтернативных МГТ-препаратов свидетельствует об их безопасности [4].

Menopausal hormone therapy (MHT) is recognized as the most effective treatment of vaso-motor symptoms in women during menopausal transition and in postmenopause [1, 2]. Although various alternative therapies are widely used for this purpose, there is little sufficient evidence to support them. The market of the so-called natural plant preparations has been on the rise recently, although the effects of most of such preparations are not better than those of the placebo [3]. Many physicians and women mistakenly believe that absence of data on any adverse effects of alternative MHT medicines evidences their safety. [4]

дополнительные альтернативные методы лечениятканеспецифический эстрогеновый комплексселективные ингибиторы обратного захвата серотонина и норадреналинаменопаузальные симптомыфитоэстрогеныmenopausal symptomsadditional alternative therapiesphytoestrogensselective serotonin reuptake inhibitorsselective serotonin-norepinephrine reuptake inhibitorstissue selective estrogen complexmenopausal symptomsphytoestrogensReferencesde Villiers TJ, Pines A, Panay N et al. Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health. Climacteric, 2013, 16: 316-337.de Villiers TJ, Pines A, Panay N et al. Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health. Climacteric, 2013, 16: 316-337.Practice Bulletin ACOG No. 141: Management of Menopausal Symptoms. Obstet Gynecol., 2014, 123: 202-216.Practice Bulletin ACOG No. 141: Management of Menopausal Symptoms. Obstet Gynecol., 2014, 123: 202-216.Geller SE, Shulman LP, van Breemen RB et al. Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomized controlled trial. Menopause, 2009, 16: 1156-1166.Geller SE, Shulman LP, van Breemen RB et al. Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomized controlled trial. Menopause, 2009, 16: 1156-1166.Shulman LP. Has the pendulum begun to swing back? Menopause, 2014, 21(3): 211-2.Shulman LP. Has the pendulum begun to swing back? Menopause, 2014, 21(3): 211-2.Manson JE. Current recommendations: what is the clinician to do? Fertil Steril., 2014, 101: 916-921.Manson JE. Current recommendations: what is the clinician to do? Fertil Steril., 2014, 101: 916-921.Sternfeld B, LaCroix A, Caan BJ et aL Design and methods of a multi-site, multi-behavioral treatment trial for menopausal symptoms: the MsFLASH experience. Contemp Clin Trials, 2013, 35: 25-34.Sternfeld B, LaCroix A, Caan BJ et aL Design and methods of a multi-site, multi-behavioral treatment trial for menopausal symptoms: the MsFLASH experience. Contemp Clin Trials, 2013, 35: 25-34.Newton KM, Reed SD, Guthrie KA et al. Efficacy of yoga for vasomotor symptoms: a randomized controlled trial. Menopause, 2014, 21: 339-46.Newton KM, Reed SD, Guthrie KA et al. Efficacy of yoga for vasomotor symptoms: a randomized controlled trial. Menopause, 2014, 21: 339-46.Sternfeld B, Guthrie kA, Ensrud KE et al. Efficacy of exercise for menopausal symptoms: a randomized controlled trial. Menopause, 2014, 21: 330-8.Sternfeld B, Guthrie kA, Ensrud KE et al. Efficacy of exercise for menopausal symptoms: a randomized controlled trial. Menopause, 2014, 21: 330-8.Cohen LS, Joffe H, Guthrie KA et al. Efficacy of omega-3 for vasomotor symptoms treatment: a randomized controlled trial. Menopause, 2014, 21: 347-54Cohen LS, Joffe H, Guthrie KA et al. Efficacy of omega-3 for vasomotor symptoms treatment: a randomized controlled trial. Menopause, 2014, 21: 347-54Reed SD, Guthrie KA, Newton KM et al. Menopausal quality of life: RCT of yoga, exercise, and omega-3 supplements. Am J Obstet Gynecol, 2014, 210: 244Reed SD, Guthrie KA, Newton KM et al. Menopausal quality of life: RCT of yoga, exercise, and omega-3 supplements. Am J Obstet Gynecol, 2014, 210: 244Mansikkamaki K, Raitanen J, Malila N, et al. Physical activity and menopause-related quality of life - A population-based cross-sectional study. Maturitas 2015, 80: 69-74.Mansikkamaki K, Raitanen J, Malila N, et al. Physical activity and menopause-related quality of life - A population-based cross-sectional study. Maturitas 2015, 80: 69-74.Gold E, Colvin A, Avis N, et al. Longitudinal analysis of vasomotor symptoms and race/ethnicity across the menopausal transition: Study of Women's Health Across the Nation (SWAN). Am J Public Health 2006, 96: 1226-1235.Gold E, Colvin A, Avis N, et al. Longitudinal analysis of vasomotor symptoms and race/ethnicity across the menopausal transition: Study of Women's Health Across the Nation (SWAN). Am J Public Health 2006, 96: 1226-1235.Thurston RC, Sowers MR, Sternfeld B, et al. Gains in body fat and vasomotor symptom reporting over the menopausal transition: the Study of Women's Health Across the Nation. Am J Epidemiol 2009, 170: 766-774.Thurston RC, Sowers MR, Sternfeld B, et al. Gains in body fat and vasomotor symptom reporting over the menopausal transition: the Study of Women's Health Across the Nation. Am J Epidemiol 2009, 170: 766-774.Thurston RC, Ewing LJ, Low CA, et al. Behavioral weight loss for the management of menopausal hot flashes: a pilot study. Menopause 2015, 22(1): 59-65.Thurston RC, Ewing LJ, Low CA, et al. Behavioral weight loss for the management of menopausal hot flashes: a pilot study. Menopause 2015, 22(1): 59-65.Gentry-Maharaj A, Karpinskyj C, Glazer C, et al. Use and perceived efficacy of complementary and alternative medicines after discontinuation of hormone therapy: a nested United Kingdom Collaborative Trial of Ovarian Cancer Screening cohort study. Menopause 2015, 22(4): 000/000. DOI: 10.1097/gme.0000000000000330.Gentry-Maharaj A, Karpinskyj C, Glazer C, et al. Use and perceived efficacy of complementary and alternative medicines after discontinuation of hormone therapy: a nested United Kingdom Collaborative Trial of Ovarian Cancer Screening cohort study. Menopause 2015, 22(4): 000/000. DOI: 10.1097/gme.0000000000000330.Chiu H-Y, Pan C-H, Shyu Y-K, et al. Effects of acupuncture on menopause-related symptoms and quality of life in women on natural menopause: a meta-analysis of randomized controlled trials. Menopause 2015, 22: 000/000. DOI: 10.1097/gme.0000000000000260.Chiu H-Y, Pan C-H, Shyu Y-K, et al. Effects of acupuncture on menopause-related symptoms and quality of life in women on natural menopause: a meta-analysis of randomized controlled trials. Menopause 2015, 22: 000/000. DOI: 10.1097/gme.0000000000000260.Freeman EW, Sammel, Sanders RJ. Risk of long-term hot flashes after natural menopause: evidence from the Penn Ovarian Aging Study cohort. Menopause 2014, 21(9): 924-32.Freeman EW, Sammel, Sanders RJ. Risk of long-term hot flashes after natural menopause: evidence from the Penn Ovarian Aging Study cohort. Menopause 2014, 21(9): 924-32.Taku K, Melby MK, Kronenberg F, et al. Extracted or synthesized soybean isoflavones reduce menopausal hot flash frequency and severity: systematic review and meta-analysis of randomized controlled trials. Menopause 2012, 19: 776-790.Taku K, Melby MK, Kronenberg F, et al. Extracted or synthesized soybean isoflavones reduce menopausal hot flash frequency and severity: systematic review and meta-analysis of randomized controlled trials. Menopause 2012, 19: 776-790.Edena JA. Phytoestrogens for menopausal symptoms: A review. Maturitas 2012, 72: 157-159.Edena JA. Phytoestrogens for menopausal symptoms: A review. Maturitas 2012, 72: 157-159.Amato P, Young RL, Steinberg FM, et al. Effect of soy isoflavone supplementation on menopausal quality of life. Menopause 2013, 20: 443-447.Amato P, Young RL, Steinberg FM, et al. Effect of soy isoflavone supplementation on menopausal quality of life. Menopause 2013, 20: 443-447.Carmignani LO, Orcesi Pedro A, Montemor EB, et al. Effects of a soy-based dietary supplement compared with low-dose hormone therapy on the uro-genital system: a randomized, double-blind, controlled clinical trial. Menopause 2015, 22 (7): 000/000.DOI: 0.1097/gme.0000000000000380.Carmignani LO, Orcesi Pedro A, Montemor EB, et al. Effects of a soy-based dietary supplement compared with low-dose hormone therapy on the uro-genital system: a randomized, double-blind, controlled clinical trial. Menopause 2015, 22 (7): 000/000.DOI: 0.1097/gme.0000000000000380.Lethaby A, Marjoribanks J, Kronenberg F, et al. Phytoestrogens for menopausal vasomotor symptoms. Cochrane Database Syst Rev 2013, 12. CD001395.Lethaby A, Marjoribanks J, Kronenberg F, et al. Phytoestrogens for menopausal vasomotor symptoms. Cochrane Database Syst Rev 2013, 12. CD001395.Gartoulla P, Han MM. Red clover extract for alleviating hot flushes in postmenopausal women: A meta-analysis Maturitas 2014, 79: 58-64.Gartoulla P, Han MM. Red clover extract for alleviating hot flushes in postmenopausal women: A meta-analysis Maturitas 2014, 79: 58-64.Shike M, Doane AS, Russo L, et al. The Effects of Soy Supplementation on Gene Expression in Breast Cancer: A Randomized Placebo-controlled Study. J Natl Cancer Inst. 2014, 106(9).Shike M, Doane AS, Russo L, et al. The Effects of Soy Supplementation on Gene Expression in Breast Cancer: A Randomized Placebo-controlled Study. J Natl Cancer Inst. 2014, 106(9).Leach MJ, Moore V. Black cohosh (Cimicifuga spp.) for menopausal symptoms. Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No.: CD007244.Leach MJ, Moore V. Black cohosh (Cimicifuga spp.) for menopausal symptoms. Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No.: CD007244.

The authors declare that there are no conflicts of interest present.